Complications research
What are your most pressing questions about diabetes complications?
Optimising therapy
How might we treat patients with type 2 diabetes and kidney disease in the future?
Towards a cure
The mysteries of beta cell failure and why the body makes a mistake in type 1 diabetes are among the unknowns that Pr...
On the move
Dr Jeremy Robles discusses the complex picture of diabetes and migration, and how research can help to untangle the q...
From the cell to the whole body
Professor Juleen Zierath details the unknowns that are yet to be solved by research, including how the organs work in...
Moving forward
Professor Dominik Pesta on the hot topics that need more research, including individualised exercise prescriptions fo...
Life-changing answers
Professor Stephanie Amiel outlines the areas she’d like to be better understood, including type 1 diabetes immunology...
A clearer picture
A definitive answer on metformin, more detail on SGLT-2 inhibitors and the best combinations of lipid-lowering drugs ...
Attention to detail
Professor Nisa Maruthur reflects on the unknowns around type 2 diabetes prevention, complications, pharmacotherapy an...
A hopeful future
The evolving field of diabetes subtypes, what is implied by adipose tissue being composed of several types of fat cel...
On the cusp
Understanding the full spectrum of immunotherapy techniques in type 1 diabetes, the optimal approach to the obesity p...
Longer lasting
How to make lifestyle interventions more durable and how to treat insulin resistance with more acceptable medications...
Pregnancy and beyond
The cut-off for first trimester diagnosis, breastfeeding, the use of metformin and the EMERGE trial are among the top...
A fuller understanding
Why lean, younger people are being diagnosed with type 2 diabetes and the impact of diet in gestational diabetes are ...
A brighter future
Biomarkers that tell us which patients are at higher risk of beta cell dysfunction, drugs that could cure it and what...
Tackling with tech
We don’t know enough about the common denominators that link chronic conditions – Professor Cees Tack discusses exact...
A deeper understanding
What we need to know about diabetes in people with severe mental illness as well as the psychosocial aspects of diabe...
Multiplicity mysteries
What’s the course of type 2 diabetes, how should we treat it and how can we prevent it? Listen to Professor Clifford ...
Within our reach
Exercise would be easier and more beneficial for people with type 1 diabetes if we could one day find the answers to ...
Polypharmacy in type 2 diabetes
Matching the right drugs to the right people, improving cardiovascular outcomes and reducing the burden of multiple m...
Preserve, predict, prevent
Professor Bruce Wolffenbuttel on his pick of the top five research questions that would benefit our understanding of ...
Replacement strategies
Availability, safety and prevention are high on Professor Eelco de Koning’s list of priorities for research into isle...
Screen and intervene
Earlier, more tailored interventions to prevent type 1 diabetes are high on the list of research priorities for Profe...
Questions of healing
What are the mechanisms involved in wound healing? How can emerging technologies help prevent ulceration? How cost-ef...
Get it together
Integration of care, behaviour change and how we’re going to pay for everything: hear the rest of Dr João Filipe Rap...
Obesity and diabetes
How does obesity accelerate the beta cell failure that’s characteristic of type 2 diabetes? And why does NAFLD advanc...
Mission remission
We now know that weight loss can result in type 2 diabetes remission, but questions remain. What is the effect of rem...
A growing problem
With the obesity crisis showing no signs of abating, insulin resistance in children and adolescents with type 1 diabe...
A big difference
Personalised immune modulation and technology for more exact carb counting are two of the research areas that would p...
Best foot forward
Better treatments for painful diabetic neuropathy, understanding the pathomechanisms of Charcot foot and the role of ...
Fasting unknowns
What is happening to blood sugars and hormones during Ramadan fasting? Can new technologies help us manage fasting mo...
Take heart
Should we combine modern drugs? What are ideal blood pressure targets? And why are women with diabetes at such high r...
Saline replacement?
Could an ideal fluid be created to replace saline and Ringer’s lactate? This and other questions about DKA management...
Transplant goals
Finding new sources of insulin-producing cells and reducing the burden of immunosuppression are among Professor Franc...
Opportunity awaits
The rising use of diabetes technologies opens up huge opportunities to deepen our knowledge. Professor Pratik Choudha...
Time will tell
GLP-1 receptor agonists have been researched for decades, but there’s still much to discover. Professor Filip Knop fr...
The earlier the better
Professor Tina Vilsbøll from the Steno Diabetes Center, Copenhagen, on why research should focus on the initial stage...
The next 10 years
What is causing the decline of beta-cell function in type 2 diabetes and is it possible to reverse it? And what is th...
Best foot forward
Professor Andrew Boulton on the five things we need to investigate to take forward research into diabetes and the foot.
Unsolved mysteries of diabetes and the kidney
Professor Sally Marshall’s pick of the top 5 things we don’t yet know about diabetic nephropathy.
Top 5 for type 1
Professor Chantal Mathieu on what we still need to learn about type 1 diabetes.
What we need to know about type 2
Kicking off a new series, where leading experts set out research priorities for their area of diabetes, Professor Ste...